Viridian Therapeutics Inc (VRDN)

04:31 AM

Viridian Therapeutics signs manufacturing deal with WuXi Biologics for thyroid eye disease drug - marketscreener.com

04:31 AM

04:13 AM

Viridian therapeutics enters commercial manufacturing agreement with Wuxi biologics on May 24, 2026 - marketscreener.com

04:13 AM

04:05 AM

Viridian (VRDN) secures WuXi Biologics pact for long-term veligrotug manufacturing - Stock Titan

04:05 AM

May 24, 2026

Does Viridian’s Upsized Note and Equity Offering Change The Bull Case For Viridian Therapeutics (VRDN)? - Sahm

May 24, 2026

May 23, 2026

Viridian Therapeutics prices upsized $350M concurrent stock and convertible notes offerings - MSN

May 23, 2026

May 21, 2026

Viridian Therapeutics (VRDN) Prices Upsized Concurrent Public Offerings Totaling $350M - Insider Monkey

May 21, 2026

May 21, 2026

Viridian Therapeutics releases topline phase 3 TED data elegrobart - Eyes On Eyecare

May 21, 2026

May 21, 2026

VRDN Stock Price, Quote & Chart | VIRIDIAN THERAPEUTICS INC (NASDAQ:VRDN) - ChartMill

May 21, 2026

May 20, 2026

This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million - AOL.com

May 20, 2026

May 19, 2026

Viridian Therapeutics launches $250M concurrent debt and equity offerings - MSN

May 19, 2026

May 19, 2026

PDUFA decision nears as Viridian Therapeutics (VRDN) advances TED pipeline and reports Q1 results - MSN

May 19, 2026

May 17, 2026

HighVista Strategies Sells 238,243 Shares of Viridian Therapeutics in Q1 2026News and Statistics - IndexBox

May 17, 2026

May 17, 2026

This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million - The Motley Fool

May 17, 2026

May 16, 2026

Why is Viridian Therapeutics stock sinking Monday? - MSN

May 16, 2026

May 16, 2026

VRDN: Wedbush Maintains Rating but Lowers Price Target | VRDN St - GuruFocus

May 16, 2026

May 16, 2026

Evercore Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $26 - Moomoo

May 16, 2026

May 16, 2026

Liquidity Mapping Around (VRDN) Price Events - Stock Traders Daily

May 16, 2026

May 16, 2026

VRDN Maintained by Evercore ISI Group -- Price Target Lowered to $26 - GuruFocus

May 16, 2026

May 15, 2026

Viridian Therapeutics Analyst Ratings and Price Targets | NASDAQ:VRDN - Benzinga

May 15, 2026

May 15, 2026

Viridian Therapeutics Inc (VRDN) Stock Price, Quote, News & History - Benzinga

May 15, 2026

May 15, 2026

Bellevue Group (VRDN) files Schedule 13G for 6.6% ownership - Stock Titan

May 15, 2026

May 14, 2026

Viridian Therapeutics stock (US92769V1044): Q1 earnings beat and Phase 3 data boost - AD HOC NEWS

May 14, 2026

May 13, 2026

Fairmount Healthcare Fund II invests $20m in Viridian Therapeutics By Investing.com - Investing.com Australia

May 13, 2026

May 13, 2026

Viridian Therapeutics(VRDN.US) 10% Shareholder Buys US$20 Million in Common Stock - Moomoo

May 13, 2026

May 13, 2026

Fairmount-linked fund boosts Viridian (VRDN) stake with 1.18M-share open-market buy - Stock Titan

May 13, 2026

May 13, 2026

Fairmount boosts Viridian Therapeutics (VRDN) stake to 14.04% after $20M share purchase - Stock Titan

May 13, 2026

May 13, 2026

Stifel Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Cuts Target Price to $39 - Moomoo

May 13, 2026

May 13, 2026

How Strong REVEAL-2 Data and Fresh Capital Raises Could Shape Viridian Therapeutics (VRDN) Investors - Sahm

May 13, 2026

May 12, 2026

VRDN6389238 Bond Coupon Analysis — Rate & Payments - TradingView

May 12, 2026

May 12, 2026

VRDN6389238 Bond Analysis — Key Metrics - TradingView

May 12, 2026

May 12, 2026

Viridian Therapeutics stock (US92769V1044): Q1 beat with 95.8% revenue surge - AD HOC NEWS

May 12, 2026

May 12, 2026

Viridian Therapeutics, Inc. Bonds — Corporate Bond Rates - TradingView

May 12, 2026

May 11, 2026

Viridian Therapeutics Raises $359 Million in Offerings - TipRanks

May 11, 2026

May 11, 2026

[8-K] Viridian Therapeutics, Inc.\DE Reports Material Event - Stock Titan

May 11, 2026

May 10, 2026

VRDN6389238 Bond Price and Chart — FINRA:VRDN6389238 - TradingView

May 10, 2026

May 10, 2026

Number of shareholders of Viridian Therapeutics, Inc. – NASDAQ:VRDN - TradingView

May 10, 2026

May 09, 2026

Viridian Therapeutics, Inc. (VRDN) Discusses Positive Top Line Results From REVEAL-2 Phase III Trial in Chronic Thyroid Eye DiseaseSlideshow (NASDAQ:VRDN) 2026-05-09 - Seeking Alpha

May 09, 2026

May 09, 2026

Reassessing Viridian Therapeutics (VRDN) After Volatile Share Price Swings - Sahm

May 09, 2026

May 08, 2026

Deep Track files 5.30% stake in Viridian Therapeutics (NYSE: VRDN) as Schedule 13G - Stock Titan

May 08, 2026

May 08, 2026

Viridian Therapeutics (NASDAQ: VRDN) offers $225M convertibles; concurrent equity deal - Stock Titan

May 08, 2026

May 08, 2026

Viridian Therapeutics (VRDN) files 7.35M-share sale, concurrent $225M notes - Stock Titan

May 08, 2026

May 08, 2026

Why Viridian Therapeutics (VRDN) Is Up 25.9% After Phase 3 Elegrobart Win And Fresh Fundraising - Yahoo Finance

May 08, 2026

May 08, 2026

Viridian Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses - Moomoo

May 08, 2026

May 08, 2026

Viridian prices $225M convertible notes, $125M equity offering - Investing.com UK

May 08, 2026

May 07, 2026

MSN Money - MSN

May 07, 2026

May 07, 2026

Viridian Therapeutics (VRDN) Announces $350M Public Offerings fo - GuruFocus

May 07, 2026

May 07, 2026

Viridian Therapeutics Plans to Use Proceeds to Repay Debt, Fund Studies for Thyroid Eye Disease Franchise, Advance R&D >VRDN - Moomoo

May 07, 2026

May 07, 2026

Earnings Update: Viridian Therapeutics, Inc. (NASDAQ:VRDN) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance

May 07, 2026